unveil

Affymetrix Unveils Plans to Double Plant and Animal Genome Microarray Offering

Sacramento - Today, Affymetrix, Inc.announced plans to make eight new GeneChip(R) plant and animal genomearrays available in 2005 as part of its Consortia Program, includingcanine, Rhesus macaque, Medicago trancatula (legume), Brassica, tomato,citrus, poplar and sugar cane. More than 20 research presentations atthis week's Plant and Animal Genome Conference XIII in San Diego,Calif. feature...

Researchers use 3-D imaging system to unveil swimming behavior of microscopic plankton

From the surface, the ocean appears to be vast and uniform. But beneath the surface, tiny animals called zooplankton are swept into clusters and patches by ocean currents. The very survival of many zooplankton predators--from invertebrates to whales--and the success of fishermen catches can depend on their success at finding those patches. For almost a century ocean scientists have suspect...

Rice scientists unveil 'nanoegg'

Researchers at Rice University's Laboratory for Nanophotonics (LANP) have unveiled the "nanoegg," the latest addition to their family ultrasmall, light-focusing particles. A cousin of the versatile nanoshell, nanoeggs are asymmetric specks of matter whose striking optical properties can be harnessed for molecular imaging, medical diagnostics, chemical sensing and more. Nanoeggs are descri...

Guiding principles for facial transplantation unveiled

The American Society of Plastic Surgeons (ASPS) and the American Society for Reconstructive Microsurgery (ASRM) today unveiled a landmark joint document, Facial Transplantation-ASPS/ASRM Guiding Principles, to assist plastic surgeons considering participation in facial transplantation procedures. "This is truly a remarkable and historic time in plastic surgery," said Bruce Cunningham, MD a...

Darkness unveils vital metabolic fuel switch between sugar and fat

Constant darkness throws a molecular switch in mammals that shifts the body's fuel consumption from glucose to fat and induces a state of torpor in mice, a research team led by scientists at The University of Texas Medical School at Houston reports in the Jan. 19 edition of Nature. While their findings could provide new insight into mammalian hibernation, researchers note that the pivota...

More>>

unveil at Biology Products

No data found

Search unveil biology products at Google

Search unveil biology products at Yahoo

Search unveil biology products at Msn

unveil at Biology Technology

Bruker AXS unveils new X-ray detector

The new systems were unveiled at the 2005 International Union of Crystallography m...

Merge unveils next-generation imaging-informatics product

Merge, a medical imaging software and services company, will market the product, which is called Fusion RIS/PACS, to im...

Merge unveils updated medical imaging software

Merge, which has released several product upgrades this year as it attempts to recover from past financial reporting improprieties, said...

Merge Healthcare unveils diagnostic mammography tool

According to Merge, the vendor-neutral product, marketed as Merge Mammo(TM) version 7.0, will make possible simultaneous display and reading of images on d...

Green unveils $25 million stem cell plan

The reaction from <a href="http:/...

More>>

unveil at Medicine News

Ecstasy shrinks brain!!-researchers unveil the secrets of MDMA.

Drug abuse,has been at its best of raise over the past decade or two and with the increased incidence of consumption of drugs in teens.Researchers at a conference sponsored by the National Institute on Drug Abuse said that the drug known as ecstasy has a negative impact on blood flow to parts of the brain and that the effect can persist for weeks. ECSTASY is the name in vogue for the c...

Canine Painkiller unveiled by Novartis

Novartis received approval from the Food and Drug Administration to begin marketing Deramaxx, a canine painkiller, which will be used to relieve post-operative pain in dogs. This drug being produced by a Novartis facility at Puerto Rico //is the result of a development project undertaken by Novartis Animal Health that was run for several years at veterinary clinics, colleges and its manuf...

Skin cancer's secrets unveiled

Research conducted at Melbourne on skin cancer could save thousands of lives. Doctors found that nodular melanomas accounted for less than 15 per cent of melanoma cancers but caused up to 70 per cent of the deadliest type, called deep melanomas. The research shows the pimple-like melanoma is the most dangerous. However these are often missed at the start. A severe sunburn can cause a nodu...

Pfizer unveils anti-smoking drug

Pfizer's new drug was inspired by a natural remedy tested by doctors in the Soviet Union in the late 1960s. The Soviet doctors had tested a chemical called cytisine, derived from a weed sometimes called false tobacco, as a pill to help smokers kick the habit. They reported that cytisine partially activated the nicotine receptors in the brain without being addictive. Pfizer Inc. unveiled...

WHO and UNAIDS unveil plan to get 3 million AIDS patients on treatment by 2005

1 December 2003 | GENEVA -- The World Health Organization (WHO) and UNAIDS today release // detailed and concrete release the plan to reach the 3 by 5 target of providing antiretroviral treatment to three million people living with AIDS in developing countries and those in transition by the end of 2005. This is a vital step towards the ultimate goal of providing universal access to AIDS...

More>>

unveil at Medicine Products

No data found

Search unveil medicine products at Google

Search unveil medicine products at Yahoo

Search unveil medicine products at Msn

unveil at Medicine Technology

Making Science Personal: Lilly Oncology to Unveil 76 Studies at ASCO 2007

37 Thoracic Cancer Studies; 11 Breast Cancer Studies; 9 TargetedAgent Studies INDIANAPOLIS, May 23, 2007 /PRNewswire-FirstCall/ -- LillyOncology will unveil 76 studies at the 43rd Annual Meeting of theAmerican Society of Clinical Oncology (ASCO) in Chicago, Ill. fromJune 1-5, 2007. The company will present important data onGEMZAR(R) (gemcitabine HCl for injection), ALIMTA(R) (pemetrexedf...

Organon's Asenapine Effective in a Phase III Study for the Treatment of Bipolar I Disorder; Results Unveiled at 2007 APA Meeting

SAN DIEGO, May 21, 2007 /PRNewswire/ -- Asenapine -- aninvestigational drug being developed by Organon, the humanhealthcare business unit of Akzo Nobel, for bipolar I disorder andschizophrenia -- was demonstrated to be more effective than placeboin treating acute manic and mixed episodes associated with bipolarI disorder, according to new Phase III results, from a studypresented at the A...